Yizhe Chen

Also affiliated with Bristol-Myers Squibb (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones”.

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

(2020)10.21203/rs.3.rs-60168/v1

N/A

0DataRank · unranked

0 citations

Fangyi Zhu, Jared T. Hammill, Gloria Holbrook, Lei Yang, Burgess Freeman +8 more

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Malaria Journal(2021)10.1186/s12936-021-03617-1

N/A

0DataRank · unranked

23 citations

Fangyi Zhu, Jared T. Hammill, Gloria Holbrook, Lei Yang, Burgess B. Freeman +7 more

Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00813

N/A

0DataRank · unranked

12 citations

Vitaliy M. Sviripa, Liliia M. Kril, Diana Ortiz, Corinne M. Fargo, Ho Shin Kim +12 more

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Research Square (Research Square)(2021)10.21203/rs.3.rs-60168/v2

N/A

0DataRank · unranked

0 citations

Fangyi Zhu, Jared T. Hammill, Gloria Holbrook, Lei Yang, Burgess Freeman +8 more

Optimization of Orally Bioavailable Antileishmanial 2,4,5-Trisubstituted Benzamides

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00056

N/A

0DataRank · unranked

11 citations

Diana Ortiz, Tara Man Kadayat, Corinne M. Fargo, Jared T. Hammill, Yizhe Chen +9 more

Undetectable MRD Status in Patients with R/R CLL/SLL with Stable Disease after Lisocabtagene Maraleucel Treatment: Exploratory Analysis of the TRANSCEND CLL 004 Study

Blood(2023)10.1182/blood-2023-180230

N/A

0DataRank · unranked

0 citations

Sahar Ansari, Jason Wall, Ethan Thompson, Yizhe Chen, Tanya Siddiqi +6 more